From the Department of Radiology, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea (S.J.P., S.H.Y., W.L., Y.H.C.); Drug Safety Monitoring Center (D.Y.K., S.H.C., H.R.K.) and Department of Internal Medicine (K.H.S., S.H.C., H.R.K.), Seoul National University Hospital, Seoul, Korea; and Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul, Korea (K.H.S., S.H.C., H.R.K.).
Radiology. 2018 Sep;288(3):710-716. doi: 10.1148/radiol.2018172524. Epub 2018 May 22.
Purpose To evaluate premedication protocols involving administration of antihistamine and multidose corticosteroid that have been widely used in prevention of recurrent hypersensitivity reactions (HSRs) to iodinated contrast media (ICM); an evidence-based optimal preventive strategy customized for patients with mild cases has not yet been established. Materials and Methods The outcomes of patients with mild HSR who subsequently underwent contrast material-enhanced computed tomography (CT) between January 2012 and December 2015 were analyzed. For premedication, 4 mg of chlorpheniramine was intravenously administered 30 minutes prior to reexposure to ICM. Logistic regression with generalized estimating equations was used to determine the relationship between premedication and recurrence rate. Results A total of 1178 patients with mild immediate HSR were reexposed to ICM 3533 times. Among these patients, 1056 patients experienced allergylike reactions and 122 patients developed gastrointestinal reactions. With reexposure to the culprit agent without premedication, the recurrence rate was 31.1% (85 of 273 examinations). The recurrence rate decreased to 12% (105 of 872 examinations; P < .001) by only changing the culprit agent and to 7.6% (148 of 1947 examinations; P < .001) by using the combination of changing the ICM and antihistamine premedication. Changing the ICM plus antihistamine premedication was also helpful in reducing the recurrence of gastrointestinal symptoms from 16.1% to 1.8% (P = .020). However, despite changing of the ICM, some combinations of ICM did not show a prophylactic effect. Conclusion A combination of changing the culprit agent and antihistamine premedication resulted in the best preventive outcome for patients with mild immediate HSR. The optimal choice of substitute ICM could be individualized according to the culprit agent.
目的 评估广泛用于预防碘对比剂(ICM)重复过敏反应(HSR)的预处理方案,包括给予抗组胺药和多剂量皮质类固醇;尚未为轻度病例患者制定针对这种情况的最佳预防策略。
材料与方法 分析了 2012 年 1 月至 2015 年 12 月间随后行对比增强 CT 检查的轻度 HSR 患者的结局。对于预处理,在再次暴露于 ICM 前 30 分钟静脉给予 4mg 氯苯那敏。采用广义估计方程的逻辑回归来确定预处理与复发率之间的关系。
结果 共有 1178 例轻度即刻型 HSR 患者再次暴露于 ICM 3533 次。其中 1056 例患者出现过敏样反应,122 例患者出现胃肠道反应。未行预处理而再次暴露于致敏剂时,复发率为 31.1%(85/273 次检查)。仅改变致敏剂时,复发率降至 12%(872 次检查中的 105 次;P<0.001);而联合使用改变 ICM 和抗组胺药预处理时,复发率降至 7.6%(1947 次检查中的 148 次;P<0.001)。联合使用改变 ICM 和抗组胺药预处理也有助于将胃肠道症状的复发率从 16.1%降至 1.8%(P=0.020)。但是,尽管改变了 ICM,某些 ICM 组合并未显示出预防作用。
结论 对于轻度即刻型 HSR 患者,联合使用改变致敏剂和抗组胺药预处理可获得最佳预防效果。替代 ICM 的最佳选择可根据致敏剂个体化确定。